FBXL6 is a vulnerability in AML and unmasks proteolytic cleavage as a major experimental pitfall in myeloid cells.
Sperk A, Gabriel A, Koch D, Augsburger A, Sanchez V, Brockelt D, Öllinger R, Engleitner T, Giansanti P, Ludwig R, Auf der Maur P, Walter W, Haferlach T, Jeremias I, Rad R, Steigenberger B, Kuster B, Eichner R, Bassermann F.
Sperk A, et al. Among authors: augsburger a.
Leukemia. 2024 Sep;38(9):2027-2031. doi: 10.1038/s41375-024-02345-0. Epub 2024 Jul 16.
Leukemia. 2024.
PMID: 39014197
Free PMC article.
No abstract available.